Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
BMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement Post author:GHIAA Admin Post published:April 25, 2022 Post category: Continue ReadingBMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement
Academic Institution – Company, Research Collaboration Agreement Post author:GHIAA Admin Post published:January 12, 2022 Post category: Continue ReadingAcademic Institution – Company, Research Collaboration Agreement
CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement Post author:GHIAA Admin Post published:December 14, 2021 Post category: Continue ReadingCureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
US Department of Defense – Janssen, COVID-19 Vaccine Large Scale Manufacturing Agreement Post author:GHIAA Admin Post published:September 9, 2021 Post category: Continue ReadingUS Department of Defense – Janssen, COVID-19 Vaccine Large Scale Manufacturing Agreement
CEPI – Valneva, Chikungunya Vaccine Funding Agreement Post author:GHIAA Admin Post published:August 24, 2021 Post category: Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement
BMGF – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingBMGF – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
Natick Contracting Division – Ology Bioservices, COVID-19 Procurement Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingNatick Contracting Division – Ology Bioservices, COVID-19 Procurement Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement